meta_pixel
Tapesearch Logo
Log in
Sigma Nutrition Radio

#381: Prof. Chris Packard – LDL Cholesterol, ApoB & Atherosclerosis

Sigma Nutrition Radio

Danny Lennon

Sigma, Dietetics, Evidencebased, Nutrition, Training, Health & Fitness, Science, Diet, Fitness, Evidence, Bodybuilding, Health

4.8 β€’ 626 Ratings

πŸ—“οΈ 30 March 2021

⏱️ 75 minutes

🧾️ Download transcript

Summary

Prof. Chris Packard holds an Honorary Professorship of Vascular Biochemistry at the University of Glasgow. Over his career, Professor Packard has focussed on two aspects of atherosclerosis research, lipoprotein metabolism and how it is affected by diets and drugs, and large-scale clinical trials of lipid lowering agents. He is acknowledged as one of the leading researchers in the world in this field.

Show notes available at sigmanutrition.com/episode381

Transcript

Click on a timestamp to play from that location

0:00.0

Hello and welcome to another episode of Sigma Nutrition Radio. This is episode 381 of the podcast. My name is Danny Lennon,

0:24.7

and in a few moments I'll be joined by today's co-host Alan Flanagan. And we are going to be

0:29.1

talking with Professor Chris Packard, who holds an honorary professorship of vascular biochemistry

0:35.2

at the University of Glasgow, and who is acknowledged as truly

0:40.2

one of the leading researchers in the world in the field of atherosclerosis research, lipoprotein

0:48.1

metabolism, and so on. And over the course of many years, his work has focused really on

0:54.0

those primary two areas of

0:56.0

atherosclerosis research, the lipoprotein metabolism and how it is affected by diet and drugs,

1:03.3

and then also on several large-scale clinical trials of lipid lowering agents.

1:08.7

And his group have looked at things all the way from, like I say,

1:12.7

the metabolism, all the up to use of various different drugs, to looking at inflammation,

1:18.4

to looking at insulin resistance, and really one of the true leaders in the air of atherosclerosis

1:23.4

research. So a true honor for us to be able to talk to him and to be able to pick his brain on a

1:29.3

variety of different topics that relate to not only his work, but building off in the back

1:34.1

of several topics we've discussed in previous episodes of the podcast. Now with that said,

1:39.7

this episode does get into quite a lot of the nitty gritty details and can get quite complex at times.

1:46.0

So it might be a good place to start to go back and listen to some previous episodes or to read some of our writing that relates to this topic.

1:56.0

So notably, for example, episode 350 of this podcast might be a good one to also listen to, to get more of the details that we'll build on here.

2:05.8

Or you can check out our Sigma statement that's over on the website.

2:09.7

So we did a series on heart disease risk and part one of that, which was titled cholesterol, lipoproteins, and lipids, understanding cardiovascular disease

2:18.6

risk. That statement in particular will serve a basis for many of the things we may discuss here.

2:25.9

Now, of course, that is all optional. You can listen through today here, of course, but those are

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Danny Lennon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Danny Lennon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright Β© Tapesearch 2025.